MANEJO DA PRÉ-ECLÂMPSIA PÓS-PARTO: ESTRATÉGIAS E TRATAMENTOS EFICAZES
DOI:
https://doi.org/10.36557/pbpc.v3i2.201Keywords:
Preeclampsia, pregnancy, hypertension, treatmentAbstract
Introduction: The clinical syndrome known as preeclampsia is characterized by maternal endothelial dysfunction, resulting in elevated blood pressure and several problems in vital organs. Methods: This study consisted of an integrative review conducted through the Scopus, PubMed® and SciELO databases, using the descriptors congenital Chagas disease, pregnancy and treatment. Studies published in the last 14 years, in English, Spanish or Portuguese, that addressed the topic were included. Results and discussions: Although the use of magnesium sulfate is widely recommended for the prevention of seizures in preeclampsia before delivery, its application in the postpartum period remains uncertain, especially in patients without neurological signs. Additionally, the assessment and management of volume status in patients with postpartum preeclampsia are essential, considering the high incidence of complications. The use of diuretics, such as furosemide, has been shown to be effective in reducing blood pressure and decreasing the need for rehospitalization. Conclusion: Management of postpartum preeclampsia requires rapid control of severe hypertension with medications such as labetalol and nifedipine, and the use of magnesium sulfate in cases with neurological signs. Remote monitoring and the use of diuretics help prevent complications and rehospitalizations.
Downloads
References
ACOG COMMITTEE OPINION No. 736 Optimizing Postpartum Care. Obstet Gynecol., v. 131, n. 5, p. e140–e150, 2018.
ACOG COMMITTEE OPINION No. 767 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period. Obstet Gynecol., v. 133, n. 2, p. 409–412, 2019.
AL-SAFI, Z. et al. Delayed postpartum preeclampsia and eclampsia. Obstet Gynecol., v. 118, n. 5, p. 1102–1107, 2011.
AUGER, N.; et al. Preeclampsia and Long-term Risk of Maternal Retinal Disorders. Obstet Gynecol., v. 129, p. 42–49, 2017.
BHORAT, I.; et al. Maternal cardiac haemodynamics in severe preeclampsia complicated by acute pulmonary oedema: A review. J Matern Fetal Neonatal Med., v. 30, p. 2769–2777, 2017.
BROWN, M. et al. Hypertensive disorders of pregnancy. Hypertension., v. 72, p. 24–43, 2018.
DENNIS, A. T. Transthoracic echocardiography in women with preeclampsia. Curr Opin Anaesthesiol., v. 28, n. 3, p. 254–260, 2015.
DULEY, L. The global impact of pre‐eclampsia and eclampsia. Semin Perinatol., v. 33, n. 3, p. 130–137, 2009.
GERARD, C. 10 workshops on Immunology of preeclampsia. J Reprod Immunol., v. 123, p. 94–99, 2017.
HAUSPURG, A. et al. A Postpartum Remote Hypertension Monitoring Protocol Implemented at the Hospital Level. Obstet Gynecol., v. 134, n. 4, p. 685–691, 2019.
HIRSHBERG, A.; SAMMEL, M.; SRINIVAS, S. Text Message Remote Monitoring Reduced Racial Disparities in Postpartum Blood Pressure Ascertainment. Am J Obstet Gynecol., v. 221, n. 3, 2019.
JANZARIK, W. G. et al. Preeclampsia postpartum: Impairment of cerebral autoregulation and reversible cerebral hyperperfusion. Pregnancy Hypertens., v. 17, p. 121–126, 2019.
LEE, C. S.; et al. Serous retinal detachment in preeclampsia and malignant hypertension. Eye., v. 33, p. 1707–1714, 2019.
MELCHIORRE, K.; SHARMA, R.; THILAGANATHAN, B. Cardiovascular implications in preeclampsia: an overview. Circulation., v. 130, n. 8, p. 703–714, 2014.
PERDIGAO, J. L. et al. LB 4: Furosemide for Accelerated Recovery of Blood Pressure Postpartum: a randomized placebo controlled trial (FoR BP). Am J Obstet Gynecol., v. 222, n. 1, p. S759–S760, 2020.
REDMAN, C. W. G. Hypertension in pregnancy: the NICE guidelines. Heart., v. 97, n. 23, p. 1967–1969, 2011.
SHEKHAR, S. et al. Oral Nifedipine Versus Intravenous Labetalol for Severe Hypertension During Pregnancy: A Systematic Review and Meta-Analysis. BJOG., v. 123, n. 1, 2016. DOI: 10.1111/1471-0528.13463
SHIELDS, L. et al. Early Standardized Treatment of Critical Blood Pressure Elevations Is Associated With a Reduction in Eclampsia and Severe Maternal Morbidity. Am J Obstet Gynecol., v. 216, n. 4, 2017.
TAYLOR, R. N. et al. Chesley’s Hypertensive Disorders in Pregnancy. 4. ed. Elsevier, 2015.
VIGIL-DE GRACIA, P.; LUDMIR, J. The use of magnesium sulfate for women with severe preeclampsia or eclampsia diagnosed during the postpartum period. J Matern Fetal Neonatal Med., v. 28, n. 18, p. 2207–2209, 2015.
VILCHEZ, G. et al. Differences in clinical presentation and pregnancy outcomes in antepartum preeclampsia and new-onset postpartum preeclampsia: Are these the same disorder? Obstet Gynecol Sci., v. 59, n. 6, p. 434, 2016.
WU, P. et al. Preeclampsia and future cardiovascular health: a systematic review and meta‐analysis. Circulation: Cardiovascular Quality and Outcomes, v. 10, n. 2, p. e003497, 2017.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Felipe Manoel de Oliveira Santos, Eduarda Casado Lima , Marcelo Oliveira da Silva , Cristian Marinho Xavier , Francisco José Rodrigues de Alencar , Daniel Galvão Araujo Monteiro, Gabryella Alzira Brito Vieira , Carla Emanuele de Freitas Silva Miranda , Bruna Lima Farias Batista , Marcela Cavalcante da Trindade , Natalia Quiroga Rebouças , Marcos da Silva Gomes Júnior , Marjorie Leão de Paiva Dias, Rafael Rabêlo Jeremias Guimarães , Milena de Andrade Lima

This work is licensed under a Creative Commons Attribution 4.0 International License.
Você tem o direito de:
- Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato para qualquer fim, mesmo que comercial.
- Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
- O licenciante não pode revogar estes direitos desde que você respeite os termos da licença.
De acordo com os termos seguintes:
- Atribuição — Você deve dar o crédito apropriado , prover um link para a licença e indicar se mudanças foram feitas . Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.